ReviewHealthcare (Basel, Switzerland)2017
Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management.
Review in Healthcare (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 54 citations in OpenAlex.
- Coexisting Irritable Bowel Syndrome and Overactive Bladder Are Associated with Increased Symptom Severity in Women with Fibromyalgia.Healthcare (Basel, Switzerland) · 2026Article
- Effects of Earthquake Fear and Post-Traumatic Stress Disorder on Patients with Irritable Bowel Syndrome after a Major Earthquake in Türkiye: A Multicenter Study.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026Article
- Oral Health and "Modern" Digestive Diseases: Pathophysiologic and Etiologic Factors.Biomedicines · 2024Review
- Review
- Food Intolerances, Food Allergies and IBS: Lights and Shadows.Nutrients · 2024Review
- Gut Microbiome and Lipidome Signatures in Irritable Bowel Syndrome Patients from a Low-Income, Food-Desert Area: A Pilot Study.Microorganisms · 2023Article
- Post-Infectious Irritable Bowel Syndrome after an Epidemic of Gastroenteritis in South of Iran.Middle East journal of digestive diseases · 2022Article
- Turmeric for Treatment of Irritable Bowel Syndrome: A Systematic Review of Population-Based Evidence.Iranian journal of public health · 2022Review
- An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia.Intestinal research · 2022Article
- Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?World journal of hepatology · 2021Review
- Gwakhyangjeonggi-san for irritable bowel syndrome: A protocol for systematic review and meta-analysis.Medicine · 2021Article
- Positive Correlation between nNOS and Stress-Activated Bowel Motility Is Confirmed by In Vivo HiBiT System.Cells · 2021Article
- Global Dietary Patterns and Functional Gastrointestinal Disorders.Children (Basel, Switzerland) · 2020Review
- Targeting the gut microbiota for the treatment of irritable bowel syndrome.The Kaohsiung journal of medical sciences · 2020Review
- 5-Aminosalicylic acid for treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis.Medicine · 2020Article
- Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel SyndromeFrontiers in pharmacology · 2020Article
- Potential neuro-immune therapeutic targets in irritable bowel syndrome.Therapeutic advances in gastroenterology · 2020Review
- Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet in children.World journal of clinical cases · 2019Review
- Article
- Celiac disease in Iranian irritable bowel syndrome patients; a systematic review and meta-analysis.Gastroenterology and hepatology from bed to bench · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that is characterized by symptoms of chronic abdominal pain and altered bowel habits in the absence of an overtly identifiable cause. It is the most commonly diagnosed functional gastrointestinal disorder, accounting for about one third of gastroenterology visits. It generally presents as a complex of symptoms, including psychological dysfunction. Hypersensitivity to certain foods, especially foods that contain high amounts of fructose, plays a role in the pathophysiology of IBS. Elevated consumption of high-fructose corn syrup (HFCS) has been discussed in this aspect. The treatment options for IBS are challenging and varied. In addition to dietary restrictions for HFCS-induced IBS, such as low-FODMAP (Fermentable Oligosaccharides, Disaccharide, Monosaccharides, and Polyols) diets, existing drug therapies are administered based on the predominant symptoms and IBS
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.